17-43106527-GC-AA

Variant summary

Our verdict is Uncertain significance.
+5 Uncertain · Hot
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 5 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_ModerateO5_ModerateO7_Supporting

The NM_007294.4(BRCA1):c.140_141delGCinsTT (p.Cys47Phe) variant causes a missense change. The gene BRCA1 is a tumor suppressor gene (CancerMine: 412 TSG, 22 oncogene, 49 driver citations). The gene BRCA1 is a cancer driver gene (CancerMine: 412 TSG, 22 oncogene, 49 driver citations). Note: allele frequency estimates from gnomAD may be inaccurate for this variant type (MNP or indel longer than 3 bp) due to technology limitations. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.C47G: Likely_pathogenic (ClinVar VariationId 54242, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.C47= (synonymous): Likely_benign (ClinVar VariationId 427311, 3 stars); p.C47S: unknown significance (ClinVar VariationId 868217); p.C47W: unknown significance (ClinVar VariationId 865192)

Frequency

Genomes: not found (cov: 32)

Consequence

BRCA1
NM_007294.4 missense

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 4.08

Publications

0 publications found
Variant links:
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
BRCA1 Gene-Disease associations (from GenCC):
  • BRCA1-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Fanconi anemia, complementation group S
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), ClinGen
  • pancreatic cancer, susceptibility to, 4
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_007294.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 5 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])
O5Same location/impact as known oncogenic
Same AA change as established oncogenic variant (or germline P/LP in TSG) — Moderate (O5); ClinVar same-AA oncogenic/T1: false | ClinVar same-AA SCI tier: — | CGI same-AA oncogenic: false | TSG: true | ClinVar same-AA germline P/LP: true | CIViC LOF: false | ClinVar diff-AA oncogenic: false | ClinVar diff-AA germline P/LP: true
O7Mutational hotspot or critical domain
Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 22 pathogenic, 16 benign (OR vs. background: 6.8); Variant does not impact splicing — splice-hotspot path not applicable

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_007294.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

BRCA1 NM_007294.4
MANE Select
HGVSc / HGVSpc.140_141delGCinsTTp.Cys47Phe
Exon rankN/A
missense
Prot: NP_009225.1UniProt: P38398-1
BRCA1 NM_001407581.1
HGVSc / HGVSpc.140_141delGCinsTTp.Cys47Phe
Exon rankN/A
missense
Prot: NP_001394510.1UniProt: A0A2R8Y7V5
BRCA1 NM_001407582.1
HGVSc / HGVSpc.140_141delGCinsTTp.Cys47Phe
Exon rankN/A
missense
Prot: NP_001394511.1UniProt: A0A2R8Y7V5

Ensembl Transcripts

BRCA1 ENST00000357654.9
TSL:1MANE Select
HGVSc / HGVSpc.140_141delGCinsTTp.Cys47Phe
Exon rankN/A
missense
Prot: ENSP00000350283.3UniProt: P38398-1
BRCA1 ENST00000471181.7
TSL:1
HGVSc / HGVSpc.140_141delGCinsTTp.Cys47Phe
Exon rankN/A
missense
Prot: ENSP00000418960.2UniProt: P38398-7
BRCA1 ENST00000470026.6
TSL:1
HGVSc / HGVSpc.140_141delGCinsTTp.Cys47Phe
Exon rankN/A
missense
Prot: ENSP00000419274.2UniProt: P38398-1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 2 sources
GnomAD3 genomes
Cov:32
GnomAD4 genome
Cov:32
Showing 2 sources
Tested, but no data found:GnomAD4 exomeIf GnomAD4 is missing, the position is probably not covered by the project.

ClinVar

Not reported in ClinVar

Computational Scores

PhyloP100
Uncertain4.1
Showing 1 of 1 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

1 abnormal
4 no calibration
Nucleotide level
BRCA1 SGE Normalized Scores
Meta-analysis of urn:mavedb:00000097-a-1, urn:mavedb:00000097-b-1, urn:mavedb:00000097-c-1, urn:mavedb:00000097-d-1, urn:mavedb:00000097-e-1 and 21 others
Gene
BRCA1
Assay type
Cell fitness
Mechanism
Molecular function
Model system
Immortalized human cells (Homo sapiens)
Score
-1.96
Classified as
PS3 strongFunctionally abnormalFayer calibration: Non-functional
+4 more calibrations
PS3 strongFunctionally abnormalIGVF Coding Variant Focus Group -- Controls: Missense Variants Only: Non-functional
PS3 strongFunctionally abnormalIGVF Coding Variant Focus Group -- Controls: All Variants: Non-functional
PS3 strongFunctionally abnormalRUO
ExCALIBR calibration: PS3 Strong (7)
PS3 strongFunctionally abnormalRUO
ExCALIBR calibration (ClinVar 2018): PS3 Strong (5)
Nucleotide level
Enrich2 nucleotide variant scores for BRCA1 Y2H
BRCA1 Y2H
Gene
BRCA1
Score
-2.22 · p.Cys46Phe (assay numbering)
No calibration data
This score is at approximately the 3th percentile of all variants tested in this assay.
This score has not been calibrated against ACMG evidence — shown for context only, not as clinical evidence.
Protein level
Enrich2 amino acid variant scores for BRCA1 Y2H
BRCA1 Y2H
Gene
BRCA1
Score
-2.49 · p.Cys46Phe (assay numbering)
No calibration data
This score is at approximately the 2th percentile of all variants tested in this assay.
This score has not been calibrated against ACMG evidence — shown for context only, not as clinical evidence.
Nucleotide level
Enrich2 nucleotide variant scores for BRCA1 E3
BRCA1 E3
Gene
BRCA1
Score
· p.Cys46Phe (assay numbering)
No calibration data
This score has not been calibrated against ACMG evidence — shown for context only, not as clinical evidence.
Protein level
Enrich2 amino acid variant scores for BRCA1 E3
BRCA1 E3
Gene
BRCA1
Score
· p.Cys46Phe (assay numbering)
No calibration data
This score has not been calibrated against ACMG evidence — shown for context only, not as clinical evidence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.